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Purpose. Volumetric modulated arc therapy (VMAT) for treatment of non-small cell lung cancer (NSCLC) patients potentially
changes the risk of radiation-induced pneumonitis compared with 3D conformal radiotherapy (3D CRT). We evaluate the
radiation-induced lung injury after VMAT vs 3D CRT in treatment of locally advanced non-small lung cancer.
Patients and methods. Ten consecutive patients were treated with VMAT for locally advanced non-small cell lung cancer and
retrospectively analysed and compared with ten patients treated with 3D CRT. The mean total delivered dose in both techniques
was 66Gy. Radiological follow-up was performed by CT scan. Lung changes were evaluated by a radiologist within 3 and 6 months
after treatment.
Results and conclusions. The radiation-induced lung alterations seen at CT images differ in location, extend and distribution from
those seen after VMAT vs 3D CRT. A CT appearance of radiation in a lung treated with VMAT is a ground glass opacity focal around
treated area. Nevertheless, with 3D CRT, we can see a focal consolidation in the orientation corresponding to the radiation ﬁelds.
http://dx.doi.org/10.1016/j.rpor.2013.03.301
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Introduction. Surgery is the standard treatment for stage I non small cell lung cancer (NSCLC) in operable patients. However, a
signiﬁcant number of patients are considered medically inoperable. Stereotactic body radiation therapy (SBRT)is a potentially
effective alternative treatment. Phase I and II trials of SBRT have demonstrated feasibility with excellent local control. Aims To
evaluate feasibility of SBRT in a cohort of patients treated at our institution.
Material and methods. 20 patients with stage I, non small cell lung cancer or isolated single lung metastasis considered medically
inoperable were treated from August 2011 to January 2013. Patients were positioned supine with both arms elevated above the
head. Breathing mobility was reduced by abdominal pressure. For planning purposes a thoracic CT scan was acquired with
the patient in treatment position under shallow breathing. Determination of respiratory motion was based on an additional 4-
dimensional CT scans. Gross tumor volume was contoured on axial CT slices using lung windows for tumor/lung interfaces and
mediastinal windows for tumor/soft tissue interfaces. No explicit expansion for microscopic extension was added to form the
clinical target volume and a 0.5-cm setup margin was added to the internal target volume to form the planning target volume.
The 4D-IGRT protocol (Symmetry) was characterized using a kilovoltage CB-CT scanner installed on an Elekta Synergy linear
accelerator and on-line correction of target position errors before every fraction. The prescription dose was 18Gy×3 fractions
for peripherally located lesions and 10Gy×5 fractions for centrally lesions with entire treatment lasting 1.5–2 weeks
Results. Median age was 73 years (43–84), there were 17 men and 3 women. Tumor size ranged from 0.60 to 4.20 cm and median
follow-up was 9 months. We treated 13 primary non-small cell lung cancer and 7 isolated single lung metastases. All patients
ﬁnished their SBRT course without interruptions due to toxicity, there were no >2 grade and only 1 patient developed grade 2
skin toxicity. 94% of patients achieved local control. 3 patients developed distant metastases. At follow-up completion, 2 patients
had died. The causes of death were distant progression (n=1), other diseases (n=1)
Conclusions. Stereotactic radiotherapy is a feasible procedure for the treatment of stage I non-small-cell lung cancer. It promises
high local control and reduced overall treatment time.
http://dx.doi.org/10.1016/j.rpor.2013.03.302
